Here are five key things investors need to know to start the trading day:1. Tech leads2. Peak weekA specialist trader works inside a post on the…
The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021.Andrew Kelly | ReutersMerck on Thursday said its…
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. 1.…
Pfizer’s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the…
A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. Dado Ruvic | ReutersThe Food and Drug Administration authorized Novavax’s updated…
Pfizer COVID-19 vaccine.Courtesy: PfizerThe Food and Drug Administration on Thursday approved updated Covid vaccines from Pfizer and Moderna, putting the new shots on track to reach…
Zoom In IconArrows pointing outwardsMerck’s new pneumococcal vaccine. Courtesy: MerckThe Food and Drug Administration on Monday approved Merck’s new vaccine designed to protect adults from a…
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.Hannah Mckay | ReutersThe Food and Drug Administration on Friday expanded the approval of GSK’s respiratory…
The FDA has approved Moderna’s RSV vaccine for older adults.Courtesy: ModernaThe Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial virus for adults…
Paxlovid, Pfizer’s antiviral medication to treat the coronavirus disease, is displayed in this picture taken on Oct. 7, 2022.Wolfgang Rattay | ReutersPfizer will price a five-day…